Hypomagnesemia in Critically Ill patients on Kidney Replacement Therapy
Hypomagnesemia is a common electrolyte disorder in critically ill patients and is associated with increased morbidity and mortality risk. Many clinical conditions may contribute to hypomagnesemia through different pathogenetic mechanisms. In patients with acute kidney injury (AKI) the need for continuous or prolonged intermittent kidney replacement therapy (CKRT and PIKRT, respectively) may further add to other causes of hypomagnesemia, especially when regional citrate anticoagulation (RCA) is used. Dr. DiMario will explore strategies aimed at how precisely tailoring both dialysis prescriptions and the composition of KRT fluids, as well as early magnesium supplementation and close monitoring, could represent a cornerstone in reducing KRT-related hypomagnesemia.
Dr. Ferrari will discuss the limitations of serum magnesium as a standard lab test and the advantages of ionized magnesium (iMg) testing for more effective management of dysmagnesemia in critically ill patients.
Thu, 11 Jan 2024 - Sun, 14 Jan 2024
Houston, TX 77056
Fri, 26 Jan 2024 - Sun, 28 Jan 2024
Sun, 28 Jan 2024 - Fri, 2 Feb 2024
VorarlbergLech, Vorarlberg 6764
Thu, 8 Feb 2024 - Fri, 9 Feb 2024
Sat, 24 Feb 2024 - Wed, 28 Feb 2024
Steamboat Springs, CO 80487
Sun, 25 Feb 2024 - Thu, 29 Feb 2024
Fri, 1 Mar 2024 - Sun, 3 Mar 2024